Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Celldex Therapeutics Q3 Sales $407.00K Up From $153.00K YoY

Celldex Therapeutics (NASDAQ:CLDX) reported $407.00 thousand in sales this quarter. This is a 166.01 percent increase over sales of $153.00 thousand the same period last year.
byBenzinga Newsdesk
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Celldex Therapeutics (NASDAQ:CLDX) reported $407.00 thousand in sales this quarter. This is a 166.01 percent increase over sales of $153.00 thousand the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

LifeMD’s Earnings Outlook

By Benzinga Insights
August 10, 11:33 AM
  LifeMD (NASDAQ:LFMD) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that LifeMD will report an earnings per share (EPS) of $-0.35.

LFMD